Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Instruments & Supplies

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Revenue projections:

Revenue projections for WST
Revenue projections for WST

West Pharmaceutical Services, Inc. is projected to see lower revenues than in the previous year, a trend that usually concerns investors. Declining revenues often harm a company's profitability, leading investors to exercise caution as they weigh the potential risks of continued financial downturns.

Financial Ratios:

currentRatio 3.021000
forwardPE 33.857838
debtToEquity 10.271000
earningsGrowth 0.021000
revenueGrowth 0.075000
grossMargins 0.359130
operatingMargins 0.216400
trailingEps 7.490000
forwardEps 9.147070

WST's current ratio, being 3.021, demonstrates that the company has the liquidity necessary to service its short-term debt. With strong cash reserves and current assets, WST is well-equipped to meet its immediate financial obligations without any difficulties.
West Pharmaceutical Services, Inc.'s low Debt-to-Equity ratio reflects limited reliance on debt, signaling the company is not over-leveraged. This lower financial risk suggests that West Pharmaceutical Services, Inc. has a strong capital structure, which can help sustain long-term stability and attract cautious investors.
Positive gross and operating margins for West Pharmaceutical Services, Inc. highlight the company's profitability. These metrics reflect West Pharmaceutical Services, Inc.'s efficiency in controlling costs while generating strong revenue from its core operations, signaling robust financial health.
West Pharmaceutical Services, Inc.'s forward EPS exceeding its trailing EPS means the company is expected to be more profitable this year than last. This suggests an upward trend in earnings, with forecasts indicating that West Pharmaceutical Services, Inc.'s financial performance will improve in the current financial year.

Price projections:

Price projections for WST
Price projections for WST

West Pharmaceutical Services, Inc.'s price has consistently hovered around the lower end of analysts' projections. This pattern may reflect concerns regarding the company's ability to achieve its anticipated growth.

Recommendation changes over time:

Recommendations trend for WST
Recommendations trend for WST


West Pharmaceutical Services, Inc. has garnered a buy bias from analysts recently, suggesting the stock is a good investment opportunity. This may lead to increased investor interest, as West Pharmaceutical Services, Inc. is seen as a reliable place to park money for those looking to benefit from potential market gains and company growth.